Key Points
Numerous experienced market participants are expressing support for the healthcare and pharmaceutical sectors, asserting that they are poised for future success..
As the world contends with emerging diseases and viruses, the focus remains on the healthcare sector..
The ongoing surge in the Indian pharmaceutical sector has created wealth for investors, especially those invested in healthcare companies..
Additionally, the pharmaceutical and healthcare sector serves as a defensive theme as people persist in seeking medical assistance and taking medications even during challenging times..
Examining the holdings of diversified equity funds, it is evident that large-cap-oriented portfolios typically have a moderate average exposure of 2-5% to the pharma/healthcare sector..
